HADAR ILAN (Chairman and CEO) received a stock award from SILEXION THERAPEUTICS CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/8/2026ACC: 0001178913-26-003132
DirectorOfficer· Chairman and CEO
Since Feb 2026
+10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
152.7%
6/4/2026
6.55K→16.55K
Total
Net shares
+10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/4/2026 | A · Award | +10K | — | — | 152.7% | 6.55K | 16.55K |
| Total | +10K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Stock Option (right to buy Ordinary Shares)
DirectUnderlying security
Ordinary Shares
Underlying shares
96.00
Shares owned
96.00
Exercise price
9077.10
Expiration
—
Exercise window
—
Total
Underlying
96.00
Owned
96.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy Ordinary Shares) Direct | Ordinary Shares | 9077.10 | — | — | 96.00 | 96.00 |
| Total | 96.00 | 96.00 | ||||